Global Biochips Market Research and Analysis, 2015-2021
MARKET INSIGHTS:
Global Biochips Market is predicted to grow at the CAGR of 18% during 2016-2021. A biochip is a miniaturized laboratories or microarrays that performs thousands of simultaneous biochemical reactions. Biochips are used to perform multiple tests and enable to achieve higher output and speed. Biochips Market is driven by significant demand in personalized medicine and drug discovery & development due to faster test results and accuracy. Growth & demand of Diagnostic market is boosting the global biochips market. Technological advancement and adoption of automation techniques are creating huge scope for biochips market due to faster results and enhanced efficiency of biochips products. Biochips contain very micro sensors which enable to perform speedier test in short period of time.
Research & Development in human genome project enables to explore DNA sequencing through biochips. Biochips technology is boosted by the growth and advancement of proteomics & genomics market. DNA chips are widely adopted for gene expression, gene mapping and genotyping. Biochips have wide application which includes genomics, drug discovery & development, proteomics & genomics. In Vitro Diagnostics (IVD) & Point of Care Diagnostics (POC) are growing at a significant rate due to huge demand from developed and emerging economies. Rising life style oriented diseases such as CVD, CHD, Cancer, Diabetes and other lingering diseases are boosting the biochips market.
Global Biochips Market by application has wide variety among DNA chips market, Lab on a Chip Market and Protein Chips Market which are boosting the global Biochips Market. Technological advancement and R&D are the key strategies adopted by the Biochips companies to stay competitive. Baby Biochips is in nascent stage and expected to boost the chances of conception in infertile couples in near future. The report covers the patent analysis and research & development scenario of global Biochips market.
GEOGRAPHICAL INSIGHTS:
North America has the highest contribution to Global Biochips Market followed by Europe due to significant adoption of Biochips in hospitals, research centers and academic institutes. North America is contributing nearly half of the total market share due to huge adoption of Biochips applications and huge investment in Biochips market. Untapped APAC region such as China, India, Japan and Korea are expected to create huge opportunity for global Biochips market due to huge demand of Biochips application for diagnostics. APAC region is predicted to be a lucrative region due to rising life style oriented diseases, increase in adoption of biochips in research institutes and hospitals and improved healthcare spending. Competitive Insights:
The Key players of Global Biochips Market includes: Abbott Laboratories, Affymetrix Inc., Agilent Technologies, Inc., Biofluidix GMBH, Bio-Rad Laboratories Inc., Cellix, Cepheid Inc., Compugen, Epigem Ltd, Fluidigm Corporation, GE Healthcare, Helicos Bioscences, Illumina, Inc., Lifesensors, Medtronic, Micropoint Bioscience, Inc, Perkinelmer, Inc., Roche Diagnostics, Silicon Biosystems, Thermo Fisher Scientific, Inc. R&D, Partnership, product launch and Collaboration are the key winning strategies adopted by Global Biochips Market players across the globe.
MARKET SEGMENTATION:
Global Biochips Market is segmented on the basis of type, fabrication, end user and region. Global Biochips Market by type includes DNA chips market, Lab on a Chips, Protein Chips and other arrays Market. Global Biochips Market by Fabrication technology includes Microarrays, Microfluidics market. Global Biochips Market by end user includes Hospitals, Diagnostic centers, Research Institutes, Academic Institutes and other end user.
Global Biochips Market is predicted to grow at the CAGR of 18% during 2016-2021. A biochip is a miniaturized laboratories or microarrays that performs thousands of simultaneous biochemical reactions. Biochips are used to perform multiple tests and enable to achieve higher output and speed. Biochips Market is driven by significant demand in personalized medicine and drug discovery & development due to faster test results and accuracy. Growth & demand of Diagnostic market is boosting the global biochips market. Technological advancement and adoption of automation techniques are creating huge scope for biochips market due to faster results and enhanced efficiency of biochips products. Biochips contain very micro sensors which enable to perform speedier test in short period of time.
Research & Development in human genome project enables to explore DNA sequencing through biochips. Biochips technology is boosted by the growth and advancement of proteomics & genomics market. DNA chips are widely adopted for gene expression, gene mapping and genotyping. Biochips have wide application which includes genomics, drug discovery & development, proteomics & genomics. In Vitro Diagnostics (IVD) & Point of Care Diagnostics (POC) are growing at a significant rate due to huge demand from developed and emerging economies. Rising life style oriented diseases such as CVD, CHD, Cancer, Diabetes and other lingering diseases are boosting the biochips market.
Global Biochips Market by application has wide variety among DNA chips market, Lab on a Chip Market and Protein Chips Market which are boosting the global Biochips Market. Technological advancement and R&D are the key strategies adopted by the Biochips companies to stay competitive. Baby Biochips is in nascent stage and expected to boost the chances of conception in infertile couples in near future. The report covers the patent analysis and research & development scenario of global Biochips market.
GEOGRAPHICAL INSIGHTS:
North America has the highest contribution to Global Biochips Market followed by Europe due to significant adoption of Biochips in hospitals, research centers and academic institutes. North America is contributing nearly half of the total market share due to huge adoption of Biochips applications and huge investment in Biochips market. Untapped APAC region such as China, India, Japan and Korea are expected to create huge opportunity for global Biochips market due to huge demand of Biochips application for diagnostics. APAC region is predicted to be a lucrative region due to rising life style oriented diseases, increase in adoption of biochips in research institutes and hospitals and improved healthcare spending. Competitive Insights:
The Key players of Global Biochips Market includes: Abbott Laboratories, Affymetrix Inc., Agilent Technologies, Inc., Biofluidix GMBH, Bio-Rad Laboratories Inc., Cellix, Cepheid Inc., Compugen, Epigem Ltd, Fluidigm Corporation, GE Healthcare, Helicos Bioscences, Illumina, Inc., Lifesensors, Medtronic, Micropoint Bioscience, Inc, Perkinelmer, Inc., Roche Diagnostics, Silicon Biosystems, Thermo Fisher Scientific, Inc. R&D, Partnership, product launch and Collaboration are the key winning strategies adopted by Global Biochips Market players across the globe.
MARKET SEGMENTATION:
Global Biochips Market is segmented on the basis of type, fabrication, end user and region. Global Biochips Market by type includes DNA chips market, Lab on a Chips, Protein Chips and other arrays Market. Global Biochips Market by Fabrication technology includes Microarrays, Microfluidics market. Global Biochips Market by end user includes Hospitals, Diagnostic centers, Research Institutes, Academic Institutes and other end user.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PATENT ANALYSIS
2.6. ANALYST INSIGHT
2.6.1. KEY FINDINGS
2.6.2. RECOMMENDATION
2.6.3. CONCLUSION
2.7. REGULATION
2.7.1. REGULATIONS ON TAX POLICIES
2.7.1.1. UNITED STATES
2.7.1.2. EUROPEAN UNION
2.7.1.3. CHINA
2.7.1.4. INDIA
2.7.1.5. REST OF THE WORLD
2.7.2. REGULATIONS ON MEDICAL DEVICES
2.7.2.1. UNITED STATES
2.7.2.2. EUROPEAN UNION
2.7.2.3. CHINA
2.7.2.4. INDIA
2.7.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISE IN ADOPTION OF PERSONALIZED MEDICINES
3.1.2. TECHNOLOGICAL ADVANCEMENT IN BIOCHIPS MARKET
3.1.3. ADVANCEMENT IN PROTEOMICS & GENOMICS
3.1.4. RISE IN ADOPTION OF BIOCHIPS AND GROWING APPLICATIONS
3.1.5. R&D IN HUMAN GENOME PROJECT
3.1.6. ADVANCEMENT IN DRUG DISCOVERY & DEVELOPMENT
3.1.7. INNOVATION IN BIOCHIPS TO DRIVE THE MARKET
3.1.8. RISING LIFE STYLE ORIENTED DISEASES AND OTHER LINGERING DISEASES
3.2. RESTRAINT
3.2.1. STRINGENT REGULATIONS AND GOVERNMENT POLICIES
3.2.2. HIGH COST OF BIOCHIPS PRODUCTS
3.3. OPPORTUNITY
3.3.1. RESEARCH & DEVELOPMENT IN BIOCHIPS
3.3.2. BABY BIOCHIPS TO BOOST THE CHANCES OF CONCEPTION IN INFERTILE COUPLES
3.3.3. DEVELOPMENT IN HUMAN GENOME PROJECT
3.3.4. UNTAPPED APAC REGION HAS HUGE OPPORTUNITY FOR BIOCHIPS MARKET
MARKET SEGMENTATION
4.1. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
4.1.1. GLOBAL DNA CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.1.1. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.2. GLOBAL GENE EXPRESSION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.3. GLOBAL SNP IDENTIFICATION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.5. GLOBAL CANCER DIAGNOSTIC & TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.6. OTHER BIOCHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2. GLOBAL LAB ON A CHIP MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.2.1. GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.2. GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.3. GLOBAL PROTEOMICS & GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.4. GLOBAL IVD & POC MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.5. GLOBAL CLINICAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.6. OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3. GLOBAL PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.3.1. GLOBAL EXPRESSION PROFILING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.2. GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.3. GLOBAL PROTEOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.4. GLOBAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.6. OTHER PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.4. GLOBAL ARRAYS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.4.1. GLOBAL CELL ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.4.2. GLOBAL TISSUE ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY FABRICATION TECHNOLOGY, 2015-2021, ($ MILLIONS)
4.2.1. GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2. GLOBAL MICROFLUIDICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021, ($ MILLIONS)
4.3.1. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.2. GLOBAL DIAGNOSTIC CENTRES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.3. GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.4. GLOBAL ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.5. GLOBAL OTHER END USER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. INTRODUCTION
7.1.2. ABBOTT LABORATORIES PRODUCT PORTFOLIO
7.1.3. ABBOTT LABORATORIES RECENT ACTIVITIES
7.1.4. ABBOTT LABORATORIES SWOT ANALYSIS
7.2. AFFYMETRIX INC.
7.2.1. INTRODUCTION
7.2.2. AFFYMETRIX INC. PRODUCT PORTFOLIO
7.2.3. AFFYMETRIX INC. RECENT ACTIVITIES
7.2.4. AFFYMETRIX INC. SWOT ANALYSIS
7.3. AGILENT TECHNOLOGIES, INC.
7.3.1. INTRODUCTION
7.3.2. AGILENT TECHNOLOGIES, INC. PRODUCT PORTFOLIO
7.3.3. AGILENT TECHNOLOGIES, INC. RECENT ACTIVITIES
7.3.4. AGILENT TECHNOLOGIES, INC. SWOT ANALYSIS
7.4. BIOFLUIDIX GMBH
7.4.1. INTRODUCTION
7.4.2. BIOFLUIDIX GMBH PRODUCT PORTFOLIO
7.4.3. BIOFLUIDIX GMBH RECENT ACTIVITIES
7.4.4. BIOFLUIDIX GMBH SWOT ANALYSIS
7.5. BIO-RAD LABORATORIES INC.
7.5.1. INTRODUCTION
7.5.2. BIO-RAD LABORATORIES INC. PRODUCT PORTFOLIO
7.5.3. BIO-RAD LABORATORIES INC. RECENT ACTIVITIES
7.5.4. BIO-RAD LABORATORIES INC. SWOT ANALYSIS
7.6. CELLIX
7.6.1. INTRODUCTION
7.6.2. CELLIX PRODUCT PORTFOLIO
7.6.3. CELLIX RECENT ACTIVITIES
7.6.4. CELLIX SWOT ANALYSIS
7.7. CEPHEID INC.
7.7.1. INTRODUCTION
7.7.2. CEPHEID INC. PRODUCT PORTFOLIO
7.7.3. CEPHEID INC. RECENT ACTIVITIES
7.7.4. CEPHEID INC. SWOT ANALYSIS
7.8. COMPUGEN
7.8.1. INTRODUCTION
7.8.2. COMPUGEN PRODUCT PORTFOLIO
7.8.3. COMPUGEN RECENT ACTIVITIES
7.8.4. COMPUGEN SWOT ANALYSIS
7.9. EPIGEM LTD
7.9.1. INTRODUCTION
7.9.2. EPIGEM LTD PRODUCT PORTFOLIO
7.9.3. EPIGEM LTD RECENT ACTIVITIES
7.9.4. EPIGEM LTD SWOT ANALYSIS
7.10. FLUIDIGM CORPORATION
7.10.1. INTRODUCTION
7.10.2. FLUIDIGM CORPORATION PRODUCT PORTFOLIO
7.10.3. FLUIDIGM CORPORATION RECENT ACTIVITIES
7.10.4. FLUIDIGM CORPORATION SWOT ANALYSIS
7.11. GE HEALTHCARE
7.11.1. INTRODUCTION
7.11.2. GE HEALTHCARE PRODUCT PORTFOLIO
7.11.3. GE HEALTHCARE RECENT ACTIVITIES
7.11.4. GE HEALTHCARE SWOT ANALYSIS
7.12. HELICOS BIOSCENCES
7.12.1. INTRODUCTION
7.12.2. HELICOS BIOSCENCES PRODUCT PORTFOLIO
7.12.3. HELICOS BIOSCENCES RECENT ACTIVITIES
7.12.4. HELICOS BIOSCENCES SWOT ANALYSIS
7.13. ILLUMINA, INC.
7.13.1. INTRODUCTION
7.13.2. ILLUMINA, INC. PRODUCT PORTFOLIO
7.13.3. ILLUMINA, INC. RECENT ACTIVITIES
7.13.4. ILLUMINA, INC. SWOT ANALYSIS
7.14. LIFESENSORS
7.14.1. INTRODUCTION
7.14.2. LIFESENSORS PRODUCT PORTFOLIO
7.14.3. LIFESENSORS RECENT ACTIVITIES
7.14.4. LIFESENSORS SWOT ANALYSIS
7.15. MEDTRONIC
7.15.1. INTRODUCTION
7.15.2. MEDTRONIC PRODUCT PORTFOLIO
7.15.3. MEDTRONIC RECENT ACTIVITIES
7.15.4. MEDTRONIC SWOT ANALYSIS
7.16. MICROPOINT BIOSCIENCE, INC
7.16.1. INTRODUCTION
7.16.2. MICROPOINT BIOSCIENCE, INC PRODUCT PORTFOLIO
7.16.3. MICROPOINT BIOSCIENCE, INC RECENT ACTIVITIES
7.16.4. MICROPOINT BIOSCIENCE, INC SWOT ANALYSIS
7.17. PERKINELMER, INC.
7.17.1. INTRODUCTION
7.17.2. PERKINELMER, INC. PRODUCT PORTFOLIO
7.17.3. PERKINELMER, INC. RECENT ACTIVITIES
7.17.4. PERKINELMER, INC. SWOT ANALYSIS
7.18. ROCHE DIAGNOSTICS
7.18.1. INTRODUCTION
7.18.2. ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
7.18.3. ROCHE DIAGNOSTICS RECENT ACTIVITIES
7.18.4. ROCHE DIAGNOSTICS SWOT ANALYSIS
7.19. SILICON BIOSYSTEMS
7.19.1. INTRODUCTION
7.19.2. SILICON BIOSYSTEMS PRODUCT PORTFOLIO
7.19.3. SILICON BIOSYSTEMS RECENT ACTIVITIES
7.19.4. SILICON BIOSYSTEMS SWOT ANALYSIS
7.20. THERMO FISHER SCIENTIFIC, INC.
7.20.1. INTRODUCTION
7.20.2. THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
7.20.3. THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
7.20.4. THERMO FISHER SCIENTIFIC, INC. SWOT ANALYSIS
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PATENT ANALYSIS
2.6. ANALYST INSIGHT
2.6.1. KEY FINDINGS
2.6.2. RECOMMENDATION
2.6.3. CONCLUSION
2.7. REGULATION
2.7.1. REGULATIONS ON TAX POLICIES
2.7.1.1. UNITED STATES
2.7.1.2. EUROPEAN UNION
2.7.1.3. CHINA
2.7.1.4. INDIA
2.7.1.5. REST OF THE WORLD
2.7.2. REGULATIONS ON MEDICAL DEVICES
2.7.2.1. UNITED STATES
2.7.2.2. EUROPEAN UNION
2.7.2.3. CHINA
2.7.2.4. INDIA
2.7.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISE IN ADOPTION OF PERSONALIZED MEDICINES
3.1.2. TECHNOLOGICAL ADVANCEMENT IN BIOCHIPS MARKET
3.1.3. ADVANCEMENT IN PROTEOMICS & GENOMICS
3.1.4. RISE IN ADOPTION OF BIOCHIPS AND GROWING APPLICATIONS
3.1.5. R&D IN HUMAN GENOME PROJECT
3.1.6. ADVANCEMENT IN DRUG DISCOVERY & DEVELOPMENT
3.1.7. INNOVATION IN BIOCHIPS TO DRIVE THE MARKET
3.1.8. RISING LIFE STYLE ORIENTED DISEASES AND OTHER LINGERING DISEASES
3.2. RESTRAINT
3.2.1. STRINGENT REGULATIONS AND GOVERNMENT POLICIES
3.2.2. HIGH COST OF BIOCHIPS PRODUCTS
3.3. OPPORTUNITY
3.3.1. RESEARCH & DEVELOPMENT IN BIOCHIPS
3.3.2. BABY BIOCHIPS TO BOOST THE CHANCES OF CONCEPTION IN INFERTILE COUPLES
3.3.3. DEVELOPMENT IN HUMAN GENOME PROJECT
3.3.4. UNTAPPED APAC REGION HAS HUGE OPPORTUNITY FOR BIOCHIPS MARKET
MARKET SEGMENTATION
4.1. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
4.1.1. GLOBAL DNA CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.1.1. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.2. GLOBAL GENE EXPRESSION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.3. GLOBAL SNP IDENTIFICATION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.5. GLOBAL CANCER DIAGNOSTIC & TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.1.6. OTHER BIOCHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2. GLOBAL LAB ON A CHIP MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.2.1. GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.2. GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.3. GLOBAL PROTEOMICS & GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.4. GLOBAL IVD & POC MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.5. GLOBAL CLINICAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.2.6. OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3. GLOBAL PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.3.1. GLOBAL EXPRESSION PROFILING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.2. GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.3. GLOBAL PROTEOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.4. GLOBAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.3.6. OTHER PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.4. GLOBAL ARRAYS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
4.1.4.1. GLOBAL CELL ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.1.4.2. GLOBAL TISSUE ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY FABRICATION TECHNOLOGY, 2015-2021, ($ MILLIONS)
4.2.1. GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.2.2. GLOBAL MICROFLUIDICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021, ($ MILLIONS)
4.3.1. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.2. GLOBAL DIAGNOSTIC CENTRES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.3. GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.4. GLOBAL ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
4.3.5. GLOBAL OTHER END USER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. INTRODUCTION
7.1.2. ABBOTT LABORATORIES PRODUCT PORTFOLIO
7.1.3. ABBOTT LABORATORIES RECENT ACTIVITIES
7.1.4. ABBOTT LABORATORIES SWOT ANALYSIS
7.2. AFFYMETRIX INC.
7.2.1. INTRODUCTION
7.2.2. AFFYMETRIX INC. PRODUCT PORTFOLIO
7.2.3. AFFYMETRIX INC. RECENT ACTIVITIES
7.2.4. AFFYMETRIX INC. SWOT ANALYSIS
7.3. AGILENT TECHNOLOGIES, INC.
7.3.1. INTRODUCTION
7.3.2. AGILENT TECHNOLOGIES, INC. PRODUCT PORTFOLIO
7.3.3. AGILENT TECHNOLOGIES, INC. RECENT ACTIVITIES
7.3.4. AGILENT TECHNOLOGIES, INC. SWOT ANALYSIS
7.4. BIOFLUIDIX GMBH
7.4.1. INTRODUCTION
7.4.2. BIOFLUIDIX GMBH PRODUCT PORTFOLIO
7.4.3. BIOFLUIDIX GMBH RECENT ACTIVITIES
7.4.4. BIOFLUIDIX GMBH SWOT ANALYSIS
7.5. BIO-RAD LABORATORIES INC.
7.5.1. INTRODUCTION
7.5.2. BIO-RAD LABORATORIES INC. PRODUCT PORTFOLIO
7.5.3. BIO-RAD LABORATORIES INC. RECENT ACTIVITIES
7.5.4. BIO-RAD LABORATORIES INC. SWOT ANALYSIS
7.6. CELLIX
7.6.1. INTRODUCTION
7.6.2. CELLIX PRODUCT PORTFOLIO
7.6.3. CELLIX RECENT ACTIVITIES
7.6.4. CELLIX SWOT ANALYSIS
7.7. CEPHEID INC.
7.7.1. INTRODUCTION
7.7.2. CEPHEID INC. PRODUCT PORTFOLIO
7.7.3. CEPHEID INC. RECENT ACTIVITIES
7.7.4. CEPHEID INC. SWOT ANALYSIS
7.8. COMPUGEN
7.8.1. INTRODUCTION
7.8.2. COMPUGEN PRODUCT PORTFOLIO
7.8.3. COMPUGEN RECENT ACTIVITIES
7.8.4. COMPUGEN SWOT ANALYSIS
7.9. EPIGEM LTD
7.9.1. INTRODUCTION
7.9.2. EPIGEM LTD PRODUCT PORTFOLIO
7.9.3. EPIGEM LTD RECENT ACTIVITIES
7.9.4. EPIGEM LTD SWOT ANALYSIS
7.10. FLUIDIGM CORPORATION
7.10.1. INTRODUCTION
7.10.2. FLUIDIGM CORPORATION PRODUCT PORTFOLIO
7.10.3. FLUIDIGM CORPORATION RECENT ACTIVITIES
7.10.4. FLUIDIGM CORPORATION SWOT ANALYSIS
7.11. GE HEALTHCARE
7.11.1. INTRODUCTION
7.11.2. GE HEALTHCARE PRODUCT PORTFOLIO
7.11.3. GE HEALTHCARE RECENT ACTIVITIES
7.11.4. GE HEALTHCARE SWOT ANALYSIS
7.12. HELICOS BIOSCENCES
7.12.1. INTRODUCTION
7.12.2. HELICOS BIOSCENCES PRODUCT PORTFOLIO
7.12.3. HELICOS BIOSCENCES RECENT ACTIVITIES
7.12.4. HELICOS BIOSCENCES SWOT ANALYSIS
7.13. ILLUMINA, INC.
7.13.1. INTRODUCTION
7.13.2. ILLUMINA, INC. PRODUCT PORTFOLIO
7.13.3. ILLUMINA, INC. RECENT ACTIVITIES
7.13.4. ILLUMINA, INC. SWOT ANALYSIS
7.14. LIFESENSORS
7.14.1. INTRODUCTION
7.14.2. LIFESENSORS PRODUCT PORTFOLIO
7.14.3. LIFESENSORS RECENT ACTIVITIES
7.14.4. LIFESENSORS SWOT ANALYSIS
7.15. MEDTRONIC
7.15.1. INTRODUCTION
7.15.2. MEDTRONIC PRODUCT PORTFOLIO
7.15.3. MEDTRONIC RECENT ACTIVITIES
7.15.4. MEDTRONIC SWOT ANALYSIS
7.16. MICROPOINT BIOSCIENCE, INC
7.16.1. INTRODUCTION
7.16.2. MICROPOINT BIOSCIENCE, INC PRODUCT PORTFOLIO
7.16.3. MICROPOINT BIOSCIENCE, INC RECENT ACTIVITIES
7.16.4. MICROPOINT BIOSCIENCE, INC SWOT ANALYSIS
7.17. PERKINELMER, INC.
7.17.1. INTRODUCTION
7.17.2. PERKINELMER, INC. PRODUCT PORTFOLIO
7.17.3. PERKINELMER, INC. RECENT ACTIVITIES
7.17.4. PERKINELMER, INC. SWOT ANALYSIS
7.18. ROCHE DIAGNOSTICS
7.18.1. INTRODUCTION
7.18.2. ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
7.18.3. ROCHE DIAGNOSTICS RECENT ACTIVITIES
7.18.4. ROCHE DIAGNOSTICS SWOT ANALYSIS
7.19. SILICON BIOSYSTEMS
7.19.1. INTRODUCTION
7.19.2. SILICON BIOSYSTEMS PRODUCT PORTFOLIO
7.19.3. SILICON BIOSYSTEMS RECENT ACTIVITIES
7.19.4. SILICON BIOSYSTEMS SWOT ANALYSIS
7.20. THERMO FISHER SCIENTIFIC, INC.
7.20.1. INTRODUCTION
7.20.2. THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
7.20.3. THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
7.20.4. THERMO FISHER SCIENTIFIC, INC. SWOT ANALYSIS
LIST OF TABLES
TABLE # 1 GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
TABLE # 2 GLOBAL DNA CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 3 GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 4 GLOBAL GENE EXPRESSION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 5 GLOBAL SNP IDENTIFICATION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 6 GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 7 GLOBAL CANCER DIAGNOSTIC & TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 8 OTHER BIOCHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 9 GLOBAL LAB ON A CHIP MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 10 GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 11 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 12 GLOBAL PROTEOMICS & GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 13 GLOBAL IVD & POC MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 14 GLOBAL CLINICAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 15 OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 16 GLOBAL PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 17 GLOBAL EXPRESSION PROFILING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 18 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 19 GLOBAL PROTEOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 20 GLOBAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 21 GLOBAL HIGH-THROUGHPUT SCREENING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 22 OTHER PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 23 GLOBAL ARRAYS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 24 GLOBAL CELL ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 25 GLOBAL TISSUE ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 26 GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY FABRICATION TECHNOLOGY, 2015-2021, ($ MILLIONS)
TABLE # 27 GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 28 GLOBAL MICROFLUIDICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 29 GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021, ($ MILLIONS)
TABLE # 30 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 31 GLOBAL DIAGNOSTIC CENTRES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 32 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 33 GLOBAL ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 34 GLOBAL OTHER END USER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 35 ABBOTT LABORATORIES PRODUCT PORTFOLIO
TABLE # 36 ABBOTT LABORATORIES RECENT ACTIVITIES
TABLE # 37 ABBOTT LABORATORIES SWOT ANALYSIS
TABLE # 38 AFFYMETRIX INC. PRODUCT PORTFOLIO
TABLE # 39 AFFYMETRIX INC. RECENT ACTIVITIES
TABLE # 40 AFFYMETRIX INC. SWOT ANALYSIS
TABLE # 41 AGILENT TECHNOLOGIES, INC. PRODUCT PORTFOLIO
TABLE # 42 AGILENT TECHNOLOGIES, INC. RECENT ACTIVITIES
TABLE # 43 AGILENT TECHNOLOGIES, INC. SWOT ANALYSIS
TABLE # 44 BIOFLUIDIX GMBH PRODUCT PORTFOLIO
TABLE # 45 BIOFLUIDIX GMBH RECENT ACTIVITIES
TABLE # 46 BIOFLUIDIX GMBH SWOT ANALYSIS
TABLE # 47 BIO-RAD LABORATORIES INC. PRODUCT PORTFOLIO
TABLE # 48 BIO-RAD LABORATORIES INC. RECENT ACTIVITIES
TABLE # 49 BIO-RAD LABORATORIES INC. SWOT ANALYSIS
TABLE # 50 CELLIX PRODUCT PORTFOLIO
TABLE # 51 CELLIX RECENT ACTIVITIES
TABLE # 52 CELLIX SWOT ANALYSIS
TABLE # 53 CEPHEID INC. PRODUCT PORTFOLIO
TABLE # 54 CEPHEID INC. RECENT ACTIVITIES
TABLE # 55 CEPHEID INC. SWOT ANALYSIS
TABLE # 56 COMPUGEN PRODUCT PORTFOLIO
TABLE # 57 COMPUGEN RECENT ACTIVITIES
TABLE # 58 COMPUGEN SWOT ANALYSIS
TABLE # 59 EPIGEM LTD PRODUCT PORTFOLIO
TABLE # 60 EPIGEM LTD RECENT ACTIVITIES
TABLE # 61 EPIGEM LTD SWOT ANALYSIS
TABLE # 62 FLUIDIGM CORPORATION PRODUCT PORTFOLIO
TABLE # 63 FLUIDIGM CORPORATION RECENT ACTIVITIES
TABLE # 64 FLUIDIGM CORPORATION SWOT ANALYSIS
TABLE # 65 GE HEALTHCARE PRODUCT PORTFOLIO
TABLE # 66 GE HEALTHCARE RECENT ACTIVITIES
TABLE # 67 GE HEALTHCARE SWOT ANALYSIS
TABLE # 68 HELICOS BIOSCENCES PRODUCT PORTFOLIO
TABLE # 69 HELICOS BIOSCENCES RECENT ACTIVITIES
TABLE # 70 HELICOS BIOSCENCES SWOT ANALYSIS
TABLE # 71 ILLUMINA, INC. PRODUCT PORTFOLIO
TABLE # 72 ILLUMINA, INC. RECENT ACTIVITIES
TABLE # 73 ILLUMINA, INC. SWOT ANALYSIS
TABLE # 74 LIFESENSORS PRODUCT PORTFOLIO
TABLE # 75 LIFESENSORS RECENT ACTIVITIES
TABLE # 76 LIFESENSORS SWOT ANALYSIS
TABLE # 77 MEDTRONIC PRODUCT PORTFOLIO
TABLE # 78 MEDTRONIC RECENT ACTIVITIES
TABLE # 79 MEDTRONIC SWOT ANALYSIS
TABLE # 80 MICROPOINT BIOSCIENCE, INC PRODUCT PORTFOLIO
TABLE # 81 MICROPOINT BIOSCIENCE, INC RECENT ACTIVITIES
TABLE # 82 MICROPOINT BIOSCIENCE, INC SWOT ANALYSIS
TABLE # 83 PERKINELMER, INC. PRODUCT PORTFOLIO
TABLE # 84 PERKINELMER, INC. RECENT ACTIVITIES
TABLE # 85 PERKINELMER, INC. SWOT ANALYSIS
TABLE # 86 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
TABLE # 87 ROCHE DIAGNOSTICS RECENT ACTIVITIES
TABLE # 88 ROCHE DIAGNOSTICS SWOT ANALYSIS
TABLE # 89 SILICON BIOSYSTEMS PRODUCT PORTFOLIO
TABLE # 90 SILICON BIOSYSTEMS RECENT ACTIVITIES
TABLE # 91 SILICON BIOSYSTEMS SWOT ANALYSIS
TABLE # 92 THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
TABLE # 93 THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
TABLE # 94 THERMO FISHER SCIENTIFIC, INC. SWOT ANALYSIS
TABLE # 1 GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
TABLE # 2 GLOBAL DNA CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 3 GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 4 GLOBAL GENE EXPRESSION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 5 GLOBAL SNP IDENTIFICATION MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 6 GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 7 GLOBAL CANCER DIAGNOSTIC & TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 8 OTHER BIOCHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 9 GLOBAL LAB ON A CHIP MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 10 GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 11 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 12 GLOBAL PROTEOMICS & GENOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 13 GLOBAL IVD & POC MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 14 GLOBAL CLINICAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 15 OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 16 GLOBAL PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 17 GLOBAL EXPRESSION PROFILING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 18 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 19 GLOBAL PROTEOMICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 20 GLOBAL DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 21 GLOBAL HIGH-THROUGHPUT SCREENING MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 22 OTHER PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 23 GLOBAL ARRAYS MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021, ($ MILLIONS)
TABLE # 24 GLOBAL CELL ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 25 GLOBAL TISSUE ARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 26 GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY FABRICATION TECHNOLOGY, 2015-2021, ($ MILLIONS)
TABLE # 27 GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 28 GLOBAL MICROFLUIDICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 29 GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021, ($ MILLIONS)
TABLE # 30 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 31 GLOBAL DIAGNOSTIC CENTRES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 32 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 33 GLOBAL ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 34 GLOBAL OTHER END USER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 35 ABBOTT LABORATORIES PRODUCT PORTFOLIO
TABLE # 36 ABBOTT LABORATORIES RECENT ACTIVITIES
TABLE # 37 ABBOTT LABORATORIES SWOT ANALYSIS
TABLE # 38 AFFYMETRIX INC. PRODUCT PORTFOLIO
TABLE # 39 AFFYMETRIX INC. RECENT ACTIVITIES
TABLE # 40 AFFYMETRIX INC. SWOT ANALYSIS
TABLE # 41 AGILENT TECHNOLOGIES, INC. PRODUCT PORTFOLIO
TABLE # 42 AGILENT TECHNOLOGIES, INC. RECENT ACTIVITIES
TABLE # 43 AGILENT TECHNOLOGIES, INC. SWOT ANALYSIS
TABLE # 44 BIOFLUIDIX GMBH PRODUCT PORTFOLIO
TABLE # 45 BIOFLUIDIX GMBH RECENT ACTIVITIES
TABLE # 46 BIOFLUIDIX GMBH SWOT ANALYSIS
TABLE # 47 BIO-RAD LABORATORIES INC. PRODUCT PORTFOLIO
TABLE # 48 BIO-RAD LABORATORIES INC. RECENT ACTIVITIES
TABLE # 49 BIO-RAD LABORATORIES INC. SWOT ANALYSIS
TABLE # 50 CELLIX PRODUCT PORTFOLIO
TABLE # 51 CELLIX RECENT ACTIVITIES
TABLE # 52 CELLIX SWOT ANALYSIS
TABLE # 53 CEPHEID INC. PRODUCT PORTFOLIO
TABLE # 54 CEPHEID INC. RECENT ACTIVITIES
TABLE # 55 CEPHEID INC. SWOT ANALYSIS
TABLE # 56 COMPUGEN PRODUCT PORTFOLIO
TABLE # 57 COMPUGEN RECENT ACTIVITIES
TABLE # 58 COMPUGEN SWOT ANALYSIS
TABLE # 59 EPIGEM LTD PRODUCT PORTFOLIO
TABLE # 60 EPIGEM LTD RECENT ACTIVITIES
TABLE # 61 EPIGEM LTD SWOT ANALYSIS
TABLE # 62 FLUIDIGM CORPORATION PRODUCT PORTFOLIO
TABLE # 63 FLUIDIGM CORPORATION RECENT ACTIVITIES
TABLE # 64 FLUIDIGM CORPORATION SWOT ANALYSIS
TABLE # 65 GE HEALTHCARE PRODUCT PORTFOLIO
TABLE # 66 GE HEALTHCARE RECENT ACTIVITIES
TABLE # 67 GE HEALTHCARE SWOT ANALYSIS
TABLE # 68 HELICOS BIOSCENCES PRODUCT PORTFOLIO
TABLE # 69 HELICOS BIOSCENCES RECENT ACTIVITIES
TABLE # 70 HELICOS BIOSCENCES SWOT ANALYSIS
TABLE # 71 ILLUMINA, INC. PRODUCT PORTFOLIO
TABLE # 72 ILLUMINA, INC. RECENT ACTIVITIES
TABLE # 73 ILLUMINA, INC. SWOT ANALYSIS
TABLE # 74 LIFESENSORS PRODUCT PORTFOLIO
TABLE # 75 LIFESENSORS RECENT ACTIVITIES
TABLE # 76 LIFESENSORS SWOT ANALYSIS
TABLE # 77 MEDTRONIC PRODUCT PORTFOLIO
TABLE # 78 MEDTRONIC RECENT ACTIVITIES
TABLE # 79 MEDTRONIC SWOT ANALYSIS
TABLE # 80 MICROPOINT BIOSCIENCE, INC PRODUCT PORTFOLIO
TABLE # 81 MICROPOINT BIOSCIENCE, INC RECENT ACTIVITIES
TABLE # 82 MICROPOINT BIOSCIENCE, INC SWOT ANALYSIS
TABLE # 83 PERKINELMER, INC. PRODUCT PORTFOLIO
TABLE # 84 PERKINELMER, INC. RECENT ACTIVITIES
TABLE # 85 PERKINELMER, INC. SWOT ANALYSIS
TABLE # 86 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
TABLE # 87 ROCHE DIAGNOSTICS RECENT ACTIVITIES
TABLE # 88 ROCHE DIAGNOSTICS SWOT ANALYSIS
TABLE # 89 SILICON BIOSYSTEMS PRODUCT PORTFOLIO
TABLE # 90 SILICON BIOSYSTEMS RECENT ACTIVITIES
TABLE # 91 SILICON BIOSYSTEMS SWOT ANALYSIS
TABLE # 92 THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
TABLE # 93 THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
TABLE # 94 THERMO FISHER SCIENTIFIC, INC. SWOT ANALYSIS
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. AFFYMETRIX INC.
3. AGILENT TECHNOLOGIES, INC.
4. BIOFLUIDIX GMBH
5. BIO-RAD LABORATORIES INC.
6. CELLIX
7. CEPHEID INC.
8. COMPUGEN
9. EPIGEM LTD
10. FLUIDIGM CORPORATION
11. GE HEALTHCARE
12. HELICOS BIOSCENCES
13. ILLUMINA, INC.
14. LIFESENSORS
15. MEDTRONIC
16. MICROPOINT BIOSCIENCE, INC
17. PERKINELMER, INC.
18. ROCHE DIAGNOSTICS
19. SILICON BIOSYSTEMS
20. THERMO FISHER SCIENTIFIC, INC.
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. AFFYMETRIX INC.
3. AGILENT TECHNOLOGIES, INC.
4. BIOFLUIDIX GMBH
5. BIO-RAD LABORATORIES INC.
6. CELLIX
7. CEPHEID INC.
8. COMPUGEN
9. EPIGEM LTD
10. FLUIDIGM CORPORATION
11. GE HEALTHCARE
12. HELICOS BIOSCENCES
13. ILLUMINA, INC.
14. LIFESENSORS
15. MEDTRONIC
16. MICROPOINT BIOSCIENCE, INC
17. PERKINELMER, INC.
18. ROCHE DIAGNOSTICS
19. SILICON BIOSYSTEMS
20. THERMO FISHER SCIENTIFIC, INC.
